Literature DB >> 20477510

Aptamers generated by Cell SELEX for biomarker discovery.

Youngmi Kim1, Chen Liu, Weihong Tan.   

Abstract

Biomarker discovery is essential to the advancement of our knowledge about diseases and to the development of new strategies for treatment and therapy. Among the newest technologies in this rapidly growing field is a process termed Cell SELEX by which a panel of aptamers can be generated to specifically target disease cells. Thus, Cell SELEX, together with the in vitro selection of aptamers, brings a promising approach to accelerate the progress of biomarker discovery. In this review, the Cell SELEX method and potential uses of selected aptamers are discussed. In addition, identification of potential biomarkers by using cell-binding aptamers is addressed. We believe that using the Cell SELEX strategy represents a significant improvement over current approaches to biomarker identification by the simplicity, efficiency and specificity of its application.

Entities:  

Year:  2009        PMID: 20477510     DOI: 10.2217/bmm.09.5

Source DB:  PubMed          Journal:  Biomark Med        ISSN: 1752-0363            Impact factor:   2.851


  12 in total

Review 1.  Trends in the Design and Development of Specific Aptamers Against Peptides and Proteins.

Authors:  Maryam Tabarzad; Marzieh Jafari
Journal:  Protein J       Date:  2016-04       Impact factor: 2.371

2.  Aptamer identification of brain tumor-initiating cells.

Authors:  Youngmi Kim; Qiulian Wu; Petra Hamerlik; Masahiro Hitomi; Andrew E Sloan; Gene H Barnett; Robert J Weil; Patrick Leahy; Anita B Hjelmeland; Jeremy N Rich
Journal:  Cancer Res       Date:  2013-06-24       Impact factor: 12.701

3.  Selection of aptamers specific for adipose tissue.

Authors:  Jun Liu; Huixia Liu; Kwame Sefah; Bo Liu; Ying Pu; Dimitri Van Simaeys; Weihong Tan
Journal:  PLoS One       Date:  2012-05-25       Impact factor: 3.240

Review 4.  In Vitro Selection of Cancer Cell-Specific Molecular Recognition Elements from Amino Acid Libraries.

Authors:  Ryan M Williams; Letha J Sooter
Journal:  J Immunol Res       Date:  2015-09-07       Impact factor: 4.818

5.  Aptamer based, non-PCR, non-serological detection of Chagas disease biomarkers in Trypanosoma cruzi infected mice.

Authors:  Rana Nagarkatti; Fernanda Fortes de Araujo; Charu Gupta; Alain Debrabant
Journal:  PLoS Negl Trop Dis       Date:  2014-01-16

6.  The Optimization and Characterization of an RNA-Cleaving Fluorogenic DNAzyme Probe for MDA-MB-231 Cell Detection.

Authors:  Pengcheng Xue; Shengnan He; Yu Mao; Long Qu; Feng Liu; Chunyan Tan; Yuyang Jiang; Ying Tan
Journal:  Sensors (Basel)       Date:  2017-03-21       Impact factor: 3.576

7.  Highly specific and cost-efficient detection of Salmonella Paratyphi A combining aptamers with single-walled carbon nanotubes.

Authors:  Ming Yang; Zhihui Peng; Yi Ning; Yongzhe Chen; Qin Zhou; Le Deng
Journal:  Sensors (Basel)       Date:  2013-05-22       Impact factor: 3.576

8.  Challenges and opportunities for small molecule aptamer development.

Authors:  Maureen McKeague; Maria C Derosa
Journal:  J Nucleic Acids       Date:  2012-10-24

9.  Development of RNA aptamers as molecular probes for HER2(+) breast cancer study using cell-SELEX.

Authors:  Seyedeh Alia Moosavian; Mahmoud Reza Jaafari; Seyed Mohammad Taghdisi; Fatemeh Mosaffa; Ali Badiee; Khalil Abnous
Journal:  Iran J Basic Med Sci       Date:  2015-06       Impact factor: 2.699

10.  Selective Targeting to Glioma with Nucleic Acid Aptamers.

Authors:  Shraddha Aptekar; Mohit Arora; Clare Louise Lawrence; Robert William Lea; Katherine Ashton; Tim Dawson; Jane Elizabeth Alder; Lisa Shaw
Journal:  PLoS One       Date:  2015-08-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.